Yoshida N, Arima M, Cheng G, Eda F, Hirata H, Honda K, Fukushima F, Fukuda T
Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Tochigi, 321-0293, Japan.
Cell Immunol. 2001 Feb 1;207(2):75-80. doi: 10.1006/cimm.2000.1745.
Previous studies have suggested that bronchial epithelial cells may perpetuate airway inflammation. We have reported that the bronchial epithelial cell line BEAS-2B can produce interleukin (IL)-16, a potent chemoattractant for CD4+ T cells. IL-16 is thought to regulate airway inflammation in asthmatics. Recent studies showed that IL-4 induces inflammatory cytokines in bronchial epithelial cells and that IL-9 is a candidate gene for development of asthma. The present study demonstrated that BEAS-2B cells produced specifically IL-16 by synergistic effects of IL-4 + IL-16, or IL-9 + IL-16, and that the synthesized IL-16 induced migration of CD4+ T cells. This study is a first report indicating that IL-16 production may be maintained by an autocrine machinery by epithelial cell-derived IL-16 with IL-4 and IL-9 in asthma.
以往的研究表明,支气管上皮细胞可能会使气道炎症持续存在。我们曾报道支气管上皮细胞系BEAS-2B能够产生白细胞介素(IL)-16,这是一种对CD4+ T细胞有强大趋化作用的物质。IL-16被认为可调节哮喘患者的气道炎症。最近的研究表明,IL-4可诱导支气管上皮细胞产生炎性细胞因子,且IL-9是哮喘发病的一个候选基因。本研究证明,BEAS-2B细胞通过IL-4 + IL-16或IL-9 + IL-16的协同作用特异性地产生IL-16,并且合成的IL-16可诱导CD4+ T细胞迁移。本研究首次报道,在哮喘中,上皮细胞源性IL-16与IL-4和IL-9可能通过自分泌机制维持IL-16的产生。